The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/leu2012209.pdf
Reference15 articles.
1. Bosanquet AG, Burlton AR, Bell PB, Harris AL . Ex vivo cytotoxic drug evaluation by DiSC assay to expedite identification of clinical targets: results with 8-chloro-cAMP. Br J Cancer 1997; 76: 511–518.
2. Bosanquet AG, Johnson SA, Richards SM . Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay. Br J Haematol 1999; 106: 71–77.
3. Bosanquet AG, Richards SM, Wade R, Else M, Matutes E, Dyer MJS et al. Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing. Br J Haematol 2009; 146: 384–395.
4. Catovsky D, Richards S, Matutes E, Oscier D, Dyer MJS, Bezares RF et al., on behalf of the UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group and NCRI Chronic Lymphocytic Leukaemia Working Group. Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Lancet 2007; 370: 230–239.
5. Oscier D, Wade R, Davis Z, Morilla A, Best G, Richards S et al. for the UK National Cancer Research Institute (NCRI) Chronic Lymphocytic Leukaemia Working Group. Biological risk factors identify 3 risk groups in the LRF CLL4 trial independent of treatment allocation. Hematologica 2010; 95: 1705–1712.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis;Cochrane Database of Systematic Reviews;2020-07-31
2. Precision medicine: Statistical methods for estimating adaptive treatment strategies;Bone Marrow Transplantation;2020-04-14
3. The Challenges of Informed Consent in High-Stakes, Randomized Oncology Trials: A Systematic Review;MDM Policy & Practice;2019-01
4. The long‐term outcome of patients in the LRF CLL 4 trial: the effect of salvage treatment and biological markers in those surviving 10 years;British Journal of Haematology;2015-10-12
5. Relationship between in vitro drug sensitivity and clinical response of patients to treatment in chronic lymphocytic leukemia;International Journal of Oncology;2015-01-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3